Citation Impact
Citing Papers
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
2008
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
2010
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The management of advanced thyroid cancer
2004
Activation of the cyclic AMP cascade as an ocoggenic mechanism: The thyroid example
1991
Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen
2009
Thyroid cancer
2016 Standout
Iodine-Induced Hyperthyroidism: Occurrence and Epidemiology
1998
Our ames is true: How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer
1997
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach
2007
A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems
2005
Follicular Thyroid Carcinoma
2005
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor
1995 StandoutNatureNobel
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
1994 Standout
The WHO histological classification of thyroid tumors: A commentary on the second edition
1989
Well-differentiated thyroid cancer
1994
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Costimulation of Adenylyl Cyclase and Phospholipase C by a Mutantα1B-Adrenergic Receptor Transgene Promotes Malignant Transformation of Thyroid Follicular Cells1
1997 StandoutNobel
Pulmonary capillary hemangiomatosis: A clinicopathologic review
1994
NOX enzymes and the biology of reactive oxygen
2004 Standout
Clinical classification of pulmonary hypertension
2004 Standout
UREIDOPENICILLINS AND BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONS
2000
Follicular Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome
1991
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns
2004
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Contemporary diagnostic approach to the thyroid nodule
2006
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family
2000
Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
2010
Papillary and Follicular Thyroid Carcinoma
1998
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States
2004
Low-risk differentiated thyroid cancer: The need for selective treatment
1997
Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma
2009
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
The H2O2-Generating System Modulates Protein Iodination and the Activity of the Pentose Phosphate Pathway in Dog Thyroid*
1991
Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: Comparison of cyclic AMP-dependent and -independent cell cycles
1996 StandoutNobel
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
1995 Standout
Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer
2004
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
2007
Risk stratification of patients with locally aggressive differentiated thyroid cancer
2010
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
1990 Standout
The Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound Infection
1992 Standout
Staging Systems for Papillary Thyroid Carcinoma
2007
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
2013
The superfamily of heptahelical receptors
2000 StandoutNobel
Mitogenic Signaling via G Protein-Coupled Receptors
1996 StandoutNobel
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
2011
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Subclinical Thyroid Disease
2004 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Prognostic Importance of Histologic Vascular Invasion in Papillary Thyroid Carcinoma
2005
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
1993 Nature
Prospective multicenter study of thyroid carcinoma treatment
1998
Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid
1987
ATP, bradykinin, TRH and TSH activate the Ca2+-phosphatidylinositol cascade of human thyrocytes in primary culture
1991
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα
1993 StandoutNatureNobel
Seven transmembrane receptors—A brief personal retrospective
2006 StandoutNobel
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
1998 Standout
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
1997
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Prognostic factors for thyroid carcinoma
1997
Differentiated Thyroid Cancer
1998
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma
1999
Staging Systems for Papillary Thyroid Carcinoma
2007
Papillary and follicular thyroid cancer
1987
Medical management of thyroid cancer: a risk adapted approach
2008
Update on Differentiated Thyroid Cancer Staging
2014
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications
2004
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Multiple Facets of the Modulation of Growth by cAMP
1995
Structural Instability of a Constitutively Active G Protein-coupled Receptor
1997 StandoutNobel
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
1991 Standout
In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy Is Associated with Significantly Worse Clinical Outcomes Than Only an Incomplete Thyroglobulin Response
2011
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?
2015
Prognostic Scoring Systems in Patients with Follicular Thyroid Cancer: A Comparison of Different Staging Systems in Predicting the Patient Outcome
2004
Outcomes and Prognostic Factors of 251 Patients with Minimally Invasive Follicular Thyroid Carcinoma
2012
Papillary Thyroid Carcinomas with Lung Metastases
2004
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Does the method of management of papillary thyroid carcinoma make a difference in outcome?
1994
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
1987 Standout
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
1998
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c‐erbB‐2 protein, estrogen receptor related protein, p21‐ras protein, and proliferation indicators in relation to tumor recurrences and patient survival
1995
Clinical prognostic index for recurrence of papillary thyroid carcinoma including intraoperative findings
2012
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up
1986
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
1985
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
1993
Multifactorial analysis of survival in thyroid cancer: Pitfalls of applying the results of published studies to another population
1986
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Is Above Age 45 Appropriate for Upstaging Well-Differentiated Papillary Thyroid Cancer?
2013
Management of Low-Risk Differentiated Thyroid Cancer
2007
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
1997
Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
1994
Three Decades of β-Lactamase Inhibitors
2010 Standout
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
2000
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group
1984
Application of Staging Systems for Differentiated Thyroid Carcinoma in an Endemic Goiter Region With Iodine Substitution
2003
Papillary Thyroid Carcinoma
1990
The Impact of Age and Gender on Papillary Thyroid Cancer Survival
2012
A comparison of different staging systems predictability of patient outcome
1997
Antibiotic Prophylaxis in Surgical Procedures
1983
Cancer treatment and survivorship statistics, 2019
2019 Standout
Simplifying the TNM System for Clinical Use in Differentiated Thyroid Cancer
2009
Using observational data from registries to compare treatments: The fallacy of omnimetrics
1984
Successful prophylaxis with tinidazole of infection after major head and neck surgery for malignant disease
1984
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Papillary Carcinoma of the Thyroid Gland
1998
Ligand-induced overexpression of a constitutively active β 2 -adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice
1997 StandoutNobel
Prognostic variables in mycosis fungoides
1981
Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks
2007
Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas
1983
Papillary thyroid carcinoma: factors influencing prognosis and current therapy.
1987
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome
1986
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy
2012
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Clinical Staging for Cutaneous T-Cell Lymphoma
1984
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery
1980 Standout
Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma
2012
Risk-Adapted Management of Thyroid Cancer
2008
Thyroid carcinoma
2003 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Pierre Dor being referenced
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group
1979
Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (A double‐blind study)
1973
IODIDE ORGANIFICATION DEFECT IN A COLD THYROID NODULE: ABSENCE OF IODIDE EFFECT ON CYCLIC AMP ACCUMULATION
1984
Malignant lymphomas and undifferentiated small cell carcinoma of the thyroid: a clinicopathological review in the light of the Kiel classification for malignant lymphomas
1978
Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin
1992
OUTPUT OF OESTROGENS, TESTOSTERONE AND THEIR PRECURSORS BY ISOLATED HUMAN ADRENAL CELLS AS COMPARED WITH THAT OF GLUCOCORTICOSTEROIDS
1976
Regulation of Cyclic Nucleotide and Prostaglandin Formation in Normal Human Thyroid Tissue and in Autonomous Nodules*
1980